Ċili - Spanjol - ISPC (Instituto de Salud Pública de Chile)

mary kay cosmetics chile s.a. - sin formulas

Ċili - Spanjol - ISPC (Instituto de Salud Pública de Chile)

mary kay cosmetics chile s.a. - sin formulas

Ċili - Spanjol - ISPC (Instituto de Salud Pública de Chile)

mary kay cosmetics chile s.a. - sin formulas

Ċili - Spanjol - ISPC (Instituto de Salud Pública de Chile)

mary kay cosmetics chile s.a. - sin formulas

Ċili - Spanjol - ISPC (Instituto de Salud Pública de Chile)

mary kay cosmetics chile s.a. - sin formulas

Ċili - Spanjol - ISPC (Instituto de Salud Pública de Chile)

mary kay cosmetics chile s.a. - sin formulas

Ċili - Spanjol - ISPC (Instituto de Salud Pública de Chile)

mary kay cosmetics chile s.a. - sin formulas

Ċili - Spanjol - ISPC (Instituto de Salud Pública de Chile)

mary kay cosmetics chile s.a. - sin formulas

Unjoni Ewropea - Spanjol - EMA (European Medicines Agency)

acino ag - clopidogrel - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - agentes antitrombóticos - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , , , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease, non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa), st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy, patients suffering from acute coronary syndrome. , ,.

Venezwela - Spanjol - Instituto Nacional de Higiene

sanofi-aventis de venezuela, s.a. - glimepirida - metformina - comprimidos recubiertos - 2mg - 500 mg